INVESTIGATION ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm - AMAG, BMCH, VRTU




  • In Business
  • 2020-10-17 18:05:00Z
  • By ACCESSWIRE
INVESTIGATION ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm - AMAG, BMCH, VRTU
INVESTIGATION ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm - AMAG, BMCH, VRTU  

NEW YORK, NY / ACCESSWIRE / October 17, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Covis Group S.à r.l. for $13.75 per share in cash. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/amag-pharmaceuticals-inc-stock-merger-covis/.

BMC Stock Holdings, Inc. (NASDAQ:BMCH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Builders FirstSource, Inc. Under the terms of the agreement, BMC shareholders will receive 1.3125 shares of Builders FirstSource common stock for each share of BMC common stock. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/bmc-stock-holdings-inc-bmch-stock-merger-builders-firstsource/.

Virtusa Corporation (NASDAQ:VRTU) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to funds affiliated with Baring Private Equity Asia for $51.35 per share. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/virtusa-corporation-vrtu-stock-merger-baring-asia/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/610913/INVESTIGATION-ALERT-Halper-Sadeh-LLP-is-Investigating-the-Following-Companies-Investors-are-Encouraged-to-Contact-the-Firm-AMAG-BMCH-VRTU

COMMENTS

More Related News

BGHL (EUR): NAV(s)
BGHL (EUR): NAV(s)

BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 26 Oct 2020.Estimated NAV Euro SharesSterling Shares Estimated NAV€    24.1723£    21.3754 Estimated MTD return     1.63 %     1.49 % Estimated YTD return     5.56 %     3.58 % Estimated ITD return   141.72 %   113.75 % NAV and returns are calculated net of management and performance feesMarket informationEuro SharesAmsterdam (AEX)London (LSE) Market Close€    17.90N/A Premium/discount to estimated NAV   -25.95 %N/A     Sterling SharesAmsterdam (AEX)London (LSE) Market CloseN/AGBX 1500.00...

BGHL (GBP): NAV(s)
BGHL (GBP): NAV(s)

BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 26 Oct 2020.Estimated NAV Euro SharesSterling Shares Estimated NAV€    24.1723£    21.3754 Estimated MTD return     1.63 %     1.49 % Estimated YTD return     5.56 %     3.58 % Estimated ITD return   141.72 %   113.75 % NAV and returns are calculated net of management and performance feesMarket informationEuro SharesAmsterdam (AEX)London (LSE) Market Close€    17.90N/A Premium/discount to estimated NAV   -25.95 %N/A     Sterling SharesAmsterdam (AEX)London (LSE) Market CloseN/AGBX 1500.00...

Turning Point Therapeutics Announces Pricing of $400 Million Public Offering of Common Stock
Turning Point Therapeutics Announces Pricing of $400 Million Public Offering of Common Stock

SAN DIEGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (Nasdaq: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the pricing of its previously announced underwritten public offering of 4,597,702 shares of its common stock at a price to the public of $87.00 per share. The gross proceeds to Turning Point from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Turning Point, are expected to be approximately $400.0 million. In addition, Turning Point has granted the underwriters a 30-day option to purchase up to an additional 689,655...

Helius Medical Technologies Announces Closing of $3.4 Million Private Placement
Helius Medical Technologies Announces Closing of $3.4 Million Private Placement

NEWTOWN, Pa., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, announced today that it has closed its previously announced private placement for total gross proceeds of approximately $3.4 million. The private placement consisted of an aggregate of 6,567,868 shares of the Company's Class A Common Stock, or common stock, and warrants to purchase an aggregate of 3,283,936 shares of common stock, at a purchase price of $0.52 per unit, consisting of one share of common stock and a warrant to purchase 0.50 shares of common stock, which aggregate share amounts reflect...

INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - CBLI, PE, PNM, CEIX
INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - CBLI, PE, PNM, CEIX

NEW YORK, NY / ACCESSWIRE / October 26, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate:Cleveland BioLabs, Inc.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business